| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |